AC Immune SA (ACIU) Institutional Ownership

Ownership Summary

AC Immune SA (NASDAQ:ACIU) showed up in the 13F filings of 18 institutional investors as of March 2018.

• These investors held 20.0% of outstanding shares in March 2018, up from 19.7% in December 2017.
• Their total shares held in ACIU increased 2.93% from the prior quarter, while the number of investors in AC Immune decreased 5.26% year over year.
• Activity in ACIU broke down as 9 buyers, 4 sellers, and 5 unchanged among 18 total holders.
• In total, institutional investors held 11.48Mn shares in AC Immune as of March 2018, up by 326.47K shares quarter on quarter, and up 939.51K shares year over year.
• BVF INC/IL leads ownership in ACIU with 19.82Mn shares as of March 31, 2018, equal to 34.55% of outstanding shares.
• The biggest buyers of AC Immune for the quarter ending March 2018 included CITADEL ADVISORS LLC (196.08K), DIMENSIONAL FUND ADVISORS LP (176.7K), JANE STREET GROUP, LLC (46.99K), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (30.04K), BlackRock, Inc. (22.11K).
• Top sellers of ACIU stock for the quarter ending March 2018 included ACADIAN ASSET MANAGEMENT LLC (367.79K), MILLENNIUM MANAGEMENT LLC (140.68K), UBS Group AG (92.72K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (58.36K), MARSHALL WACE, LLP (55.25K).
• Per Business Quant, the top 10 investors in ACIU for the quarter ending March 2018 include BVF INC/IL (19.82Mn), Wells Fargo & Company/Mn (1.0Mn), MILLENNIUM MANAGEMENT LLC (792.66K), RENAISSANCE TECHNOLOGIES LLC (624.37K), BlackRock, Inc. (524.28K), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (405.66K), DIMENSIONAL FUND ADVISORS LP (390.16K), Northern Trust Corp (278.51K), CITADEL ADVISORS LLC (267.23K), MARSHALL WACE, LLP (131.46K).